Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors

• 收藏
• 分享

专利权人:

LLC;Signal Pharmaceuticals

发明人:

Sankar, Sabita,Chopra, Rajesh,Xu, Weiming,Ning, Yuhong,Xu, Shuichan

申请号：

AU2011212927

公开号：

AU2011212927B2

申请日:

2011.02.03

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

Provided herein are methods for treating and/or preventing a cancer or a tumor syndrome in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having cancer or a tumor syndrome, characterized by a LKB 1 and/or AMPK gene or protein loss or mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/